How PBM Practices Lead to Counterfeit Drugs | Shabbir Imber Safdar, The Partnership for Safe Medicines

In this episode, Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines, discusses how PBM practices are opening doors to counterfeit drugs. Safdar explains the connection between under-reimbursement for pharmacies and the rise in counterfeit medications, shedding light on the critical need for policy changes to ensure drug safety. https://www.safemedicines.org/ https://www.bizofpharmpod.com/